Does CRIZOTINIB Cause Interstitial lung disease? 117 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 117 reports of Interstitial lung disease have been filed in association with CRIZOTINIB (Xalkori). This represents 1.2% of all adverse event reports for CRIZOTINIB.
117
Reports of Interstitial lung disease with CRIZOTINIB
1.2%
of all CRIZOTINIB reports
39
Deaths
75
Hospitalizations
How Dangerous Is Interstitial lung disease From CRIZOTINIB?
Of the 117 reports, 39 (33.3%) resulted in death, 75 (64.1%) required hospitalization, and 25 (21.4%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
Yes, Interstitial lung disease is listed as a known adverse reaction in the official FDA drug label for CRIZOTINIB.
What Other Side Effects Does CRIZOTINIB Cause?
Death (2,028)
Neoplasm progression (1,161)
Nausea (820)
Disease progression (677)
Diarrhoea (631)
Vomiting (600)
Fatigue (419)
Off label use (353)
Dyspnoea (352)
Visual impairment (315)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which CRIZOTINIB Alternatives Have Lower Interstitial lung disease Risk?
CRIZOTINIB vs CROFELEMER
CRIZOTINIB vs CROMOLYN
CRIZOTINIB vs CROTALIDAE POLYVALENT IMMUNE FAB
CRIZOTINIB vs CUBICIN
CRIZOTINIB vs CUPRIC